Among children and young adults with autoimmune liver disease (AILD), cT1 mapping correlated strongly with histology, highlighting its ability to accurately assess liver inflammatory activity and fibrosis stage. Findings support cT1 as a useful, noninvasive tool that could reduce reliance on liver biopsy for assessing and monitoring AILD.